Flow cytometric analysis of DMBA-induced early in vivo ras expression

Zoltán Gyöngyi, L. Grama, Edit Nádasi, J. Sándor, Árpád Németh, Csaba Varga, István Kiss, I. Ember

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

According to recent publications 7,12-dimethylbenz[a]anthracene (DMBA) induces not only mammary cancer but also leukemia in Long-Evans (LE) rats. After treatment with DMBA, trisomy of the chromosome bearing N-ras and mutations in the codon 61 of different ras family genes are frequent. These alterations are already visible within 48 hours. Since there are very few data on ras genes' expression in the early stages of leukemoegenesis, in our investigations LE rats were treated with DMBA and the expression of ras genes was measured within two days. DMBA was administered to outbred Long-Evans rats and the fluorescene intensity of the antibody recognizing the ras gene family was measured in femoral bone marrow cells 24 and 48 hours after the treatment. One of the bone marrow cell populations, separated by FSC and SSC, showed elevated ras gene expression at both 24 and 48 hours after the administration of the carcinogen. These results suggest that, besides the specific chromosomal aberrations and gene mutations, elevated ras gene expression could also be the marker of DMBA exposure.

Original languageEnglish
Pages (from-to)323-326
Number of pages4
JournalIn Vivo
Volume16
Issue number5
Publication statusPublished - Sep 2002

Fingerprint

9,10-Dimethyl-1,2-benzanthracene
ras Genes
Long Evans Rats
Genes
Gene expression
Rats
Bone
Gene Expression
Bearings (structural)
Bone Marrow Cells
Cells
Chromosomes
Mutation
Aberrations
Carcinogens
Trisomy
Thigh
Codon
Chromosome Aberrations
Leukemia

Keywords

  • Biomarker
  • DMBA
  • Flow cytometry
  • Gene expression
  • Long-Evans rats
  • Ras

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gyöngyi, Z., Grama, L., Nádasi, E., Sándor, J., Németh, Á., Varga, C., ... Ember, I. (2002). Flow cytometric analysis of DMBA-induced early in vivo ras expression. In Vivo, 16(5), 323-326.

Flow cytometric analysis of DMBA-induced early in vivo ras expression. / Gyöngyi, Zoltán; Grama, L.; Nádasi, Edit; Sándor, J.; Németh, Árpád; Varga, Csaba; Kiss, István; Ember, I.

In: In Vivo, Vol. 16, No. 5, 09.2002, p. 323-326.

Research output: Contribution to journalArticle

Gyöngyi, Z, Grama, L, Nádasi, E, Sándor, J, Németh, Á, Varga, C, Kiss, I & Ember, I 2002, 'Flow cytometric analysis of DMBA-induced early in vivo ras expression', In Vivo, vol. 16, no. 5, pp. 323-326.
Gyöngyi Z, Grama L, Nádasi E, Sándor J, Németh Á, Varga C et al. Flow cytometric analysis of DMBA-induced early in vivo ras expression. In Vivo. 2002 Sep;16(5):323-326.
Gyöngyi, Zoltán ; Grama, L. ; Nádasi, Edit ; Sándor, J. ; Németh, Árpád ; Varga, Csaba ; Kiss, István ; Ember, I. / Flow cytometric analysis of DMBA-induced early in vivo ras expression. In: In Vivo. 2002 ; Vol. 16, No. 5. pp. 323-326.
@article{f45472c0d42948a0ad18a3d0950591fb,
title = "Flow cytometric analysis of DMBA-induced early in vivo ras expression",
abstract = "According to recent publications 7,12-dimethylbenz[a]anthracene (DMBA) induces not only mammary cancer but also leukemia in Long-Evans (LE) rats. After treatment with DMBA, trisomy of the chromosome bearing N-ras and mutations in the codon 61 of different ras family genes are frequent. These alterations are already visible within 48 hours. Since there are very few data on ras genes' expression in the early stages of leukemoegenesis, in our investigations LE rats were treated with DMBA and the expression of ras genes was measured within two days. DMBA was administered to outbred Long-Evans rats and the fluorescene intensity of the antibody recognizing the ras gene family was measured in femoral bone marrow cells 24 and 48 hours after the treatment. One of the bone marrow cell populations, separated by FSC and SSC, showed elevated ras gene expression at both 24 and 48 hours after the administration of the carcinogen. These results suggest that, besides the specific chromosomal aberrations and gene mutations, elevated ras gene expression could also be the marker of DMBA exposure.",
keywords = "Biomarker, DMBA, Flow cytometry, Gene expression, Long-Evans rats, Ras",
author = "Zolt{\'a}n Gy{\"o}ngyi and L. Grama and Edit N{\'a}dasi and J. S{\'a}ndor and {\'A}rp{\'a}d N{\'e}meth and Csaba Varga and Istv{\'a}n Kiss and I. Ember",
year = "2002",
month = "9",
language = "English",
volume = "16",
pages = "323--326",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Flow cytometric analysis of DMBA-induced early in vivo ras expression

AU - Gyöngyi, Zoltán

AU - Grama, L.

AU - Nádasi, Edit

AU - Sándor, J.

AU - Németh, Árpád

AU - Varga, Csaba

AU - Kiss, István

AU - Ember, I.

PY - 2002/9

Y1 - 2002/9

N2 - According to recent publications 7,12-dimethylbenz[a]anthracene (DMBA) induces not only mammary cancer but also leukemia in Long-Evans (LE) rats. After treatment with DMBA, trisomy of the chromosome bearing N-ras and mutations in the codon 61 of different ras family genes are frequent. These alterations are already visible within 48 hours. Since there are very few data on ras genes' expression in the early stages of leukemoegenesis, in our investigations LE rats were treated with DMBA and the expression of ras genes was measured within two days. DMBA was administered to outbred Long-Evans rats and the fluorescene intensity of the antibody recognizing the ras gene family was measured in femoral bone marrow cells 24 and 48 hours after the treatment. One of the bone marrow cell populations, separated by FSC and SSC, showed elevated ras gene expression at both 24 and 48 hours after the administration of the carcinogen. These results suggest that, besides the specific chromosomal aberrations and gene mutations, elevated ras gene expression could also be the marker of DMBA exposure.

AB - According to recent publications 7,12-dimethylbenz[a]anthracene (DMBA) induces not only mammary cancer but also leukemia in Long-Evans (LE) rats. After treatment with DMBA, trisomy of the chromosome bearing N-ras and mutations in the codon 61 of different ras family genes are frequent. These alterations are already visible within 48 hours. Since there are very few data on ras genes' expression in the early stages of leukemoegenesis, in our investigations LE rats were treated with DMBA and the expression of ras genes was measured within two days. DMBA was administered to outbred Long-Evans rats and the fluorescene intensity of the antibody recognizing the ras gene family was measured in femoral bone marrow cells 24 and 48 hours after the treatment. One of the bone marrow cell populations, separated by FSC and SSC, showed elevated ras gene expression at both 24 and 48 hours after the administration of the carcinogen. These results suggest that, besides the specific chromosomal aberrations and gene mutations, elevated ras gene expression could also be the marker of DMBA exposure.

KW - Biomarker

KW - DMBA

KW - Flow cytometry

KW - Gene expression

KW - Long-Evans rats

KW - Ras

UR - http://www.scopus.com/inward/record.url?scp=0036762456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036762456&partnerID=8YFLogxK

M3 - Article

C2 - 12494871

AN - SCOPUS:0036762456

VL - 16

SP - 323

EP - 326

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 5

ER -